Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference Read more about Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Evoke Pharma Reports Second Quarter 2017 Results and Highlights Read more about Evoke Pharma Reports Second Quarter 2017 Results and Highlights
Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti™ Read more about Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti™
Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for Second Quarter 2017 Financial Results
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti Read more about Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
Evoke Pharma Reports First Quarter 2017 Results Read more about Evoke Pharma Reports First Quarter 2017 Results
Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 Read more about Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017
Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results Read more about Evoke Pharma Schedules Conference Call and Webcast for First Quarter 2017 Financial Results
Evoke Pharma Announces Collaboration with Spaulding Clinical Research for the Gimoti Comparative Exposure Pharmacokinetic Trial Read more about Evoke Pharma Announces Collaboration with Spaulding Clinical Research for the Gimoti Comparative Exposure Pharmacokinetic Trial
Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma's Proposed Comparative Exposure PK Trial for Gimoti NDA Read more about Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma's Proposed Comparative Exposure PK Trial for Gimoti NDA